Sarepta Therapeutics Inc

Sarepta Therapeutics Inc Stock Forecast & Price Prediction

Live Sarepta Therapeutics Inc Stock (SRPT) Price
$127.37

13

Ratings

  • Buy 13
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$127.37

P/E Ratio

P/E Ratio not available for SRPT

Volume Traded Today

$837,406

Dividend

Dividends not available for SRPT

52 Week High/low

159.89/55.25

Sarepta Therapeutics Inc Market Cap

$0

🛑 Alert: These ten stocks could have higher potential than $SRPT 🛑

Before you buy SRPT you’ll want to see this list of ten stocks that have huge potential. Want to see if SRPT made the cut? Enter your email below

SRPT Summary

Based on ratings from 13 stock analysts, the Sarepta Therapeutics Inc stock price is expected to increase by 9.13% in 12 months. This is calculated by using the average 12-month stock price forecast for Sarepta Therapeutics Inc. The lowest target is $1.00 and the highest is $224.00. Please note analyst price targets are not guaranteed and could be missed completely.

SRPT Analyst Ratings

SRPT is a stock in Health Care which has been forecasted to be worth $139.00 as an average. On the higher end, the forecast price is $224.00 USD by andreas argyrides from Wedbush and on the lower end SRPT is forecasted to be $1.00 by salveen richter from Goldman Sachs.

SRPT stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

uy ear
Mizuho Securities

Buy

$130.0

maintained

Feb 1, 2024
tazeen ahmad
Bank of America Securities

Buy

$164.0

maintained

Feb 1, 2024
hartaj singh
Oppenheimer

Hold

None

maintained

Jan 31, 2024
kostas biliouris
BMO Capital

Buy

$170.0

initiatedcoverage

Jan 31, 2024
andreas argyrides
Wedbush

Buy

$224.0

rated

Jan 30, 2024
joseph schwartz
Leerink Partners

Buy

$145.0

reiterated

Jan 29, 2024
brian skorney
Robert W. Baird

Buy

$136.0

maintained

Jan 29, 2024
anupam rama
J.P. Morgan

Buy

None

reiterated

Jan 29, 2024
gil blum
Needham

Buy

$140.0

maintained

Jan 29, 2024
david hoang
Citi

Buy

$113.0

maintained

Jan 29, 2024
ritu baral
TD Cowen

Buy

$135.0

maintained

Jan 11, 2024
salveen richter
Goldman Sachs

Buy

$1.0

reiterated

Jan 8, 2024
brian abrahams
RBC Capital

Buy

$155.0

maintained

Jan 3, 2024
stephen brozak
WBB Securities

Buy

$185.0

maintained

Dec 29, 2023
neena bitritto garg
Deutsche Bank

Buy

$109.0

initiatedcoverage

Dec 11, 2023
gena wang
Barclays

Buy

$141.0

maintained

Nov 2, 2023
kristen kluska
Cantor Fitzgerald

Hold

$40.0

downgraded

Oct 31, 2023
gavin clark gartner
Evercore ISI

Hold

$94.0

maintained

Oct 31, 2023
colin bristow
UBS

Buy

$174.0

maintained

Aug 4, 2023
judah frommer
Credit Suisse

Hold

$139.0

maintained

Aug 3, 2023

SRPT Company Information

SRPT
Sarepta Therapeutics Inc (SRPT)

When did it IPO

0

Staff Count

0

Country

Sector/Industry

/

CEO

Market Cap

$0

Sarepta Therapeutics Inc(SRPT) Financial Data

In 2023, SRPT generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SRPT's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.00%
  • Gross profit TTM $0
  • Return on assets TTM 0.00%
  • Return on equity TTM 0.00%
  • Profit margin %
  • Book value 0.00%
  • Market capitalisation $0
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year N/A
  • EPS next year N/A

Sarepta Therapeutics Inc(SRPT) Latest News

... ...

Similar Stocks to Sarepta Therapeutics Inc SRPT

🛑 Alert: These ten stocks could have higher potential than $SRPT 🛑

Before you buy SRPT you’ll want to see this list of ten stocks that have huge potential. Want to see if SRPT made the cut? Enter your email below

...

SRPT Frequently asked questions

The highest forecasted price for SRPT is $224.00 from andreas argyrides at Wedbush.

The lowest forecasted price for SRPT is $1.00 from salveen richter from Goldman Sachs

The SRPT analyst ratings consensus are 13 buy ratings, 0 hold ratings, and 0 sell ratings.